Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 199 for your search:
Drug:  vinorelbine tartrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML18527, NCT00121836

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571BDE28, 2005-001537-15, NCT00372476

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: MRC-LU23, EU-20535, EU-INCH-20535, EudraCT-2004-004438-15, NCT00253591

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: DAN-DBCG-94-03, EU-95008

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9509

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000065002, FRE-IALT, EU-96010, NCT00002823

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: FRE-FNCLCC-GFEA-09, EU-96015, FRE-GFEA-09

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LU22, EORTC-08012, EU-97016, ISRCTN25582437, NCT00003159

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Adult
Sponsor:
Protocol IDs: LLCG-BLT, MRC-BLT, EU-98003, NCT00003240

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and over
Sponsor:
Protocol IDs: ITA-MILES, ITA-GOCSI-MILES, EU-98019, NCT00003447

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RP-56976-TAX-326, RP-56976-V-326

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 70
Sponsor: Other
Protocol IDs: ITA-GEMVIN, CAN-NCIC-BR14, EU-99016, NCT00004100, BR14

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02725, ID99-303, U10CA045809, CDR0000067853, MDA-ID-99303, NCCAM, NCI-T99-0046, RTOG-0270, NCT00005838

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SANOFI-EFC3675, NCT00017459

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: LIGAND-L1069-49

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BW-P70-34972-02, NCI-V91-0069

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BW-P70-34972-01, NCI-V91-0068

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: CAN-NCIC-MA8, NCI-V92-0010, MA8

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-9308

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTI-PGT304, NCT00054197

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000306463, GOG-0204, NCT00064077

23.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: BTS-MRC-MS01, ISRCTN54469112, EU-20349, NCT00075699

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: JMTO-LC00-03, NCT00079287

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0347, S0347, NCT00103233
1     
New Search